Moreover, while DAPT demonstrated a lower 90-day mortality (1.6% vs 2.5%), the effect size was modest and did not reach statistical significance.
← all excerpts
Efficacy and Safety of Dual Antiplatelet Therapy in Acute Ischemic Stroke With Recurrent Symptoms Post-thrombolysis: A Retrospective Cohort Study From the TriNetX US Collaborative Network.
1
—
—